Medical News

RSS

FC Barcelona agrees to make Herbalife its Official Nutrition Sponsor

Herbalife Ltd. announced a three-year, multi-million dollar agreement with FC Barcelona to make Herbalife the club's Official Nutrition Sponsor. At the same time, Leo Messi has agreed to a personal sponsorship agreement.

2 Jun 2010

ZymoGenetics commences Phase 2B study of PEG-Interferon lambda in hepatitis C

ZymoGenetics, Inc. today announced the initiation of the second part of a Phase 2 clinical trial with PEG-Interferon lambda (IL-29) and ribavirin in treatment-naïve patients with chronic hepatitis C virus (HCV) infection. ZymoGenetics is developing the investigational compound PEG-Interferon lambda in collaboration with Bristol-Myers Squibb Company.

2 Jun 2010

Predictive biomarker for patients with NSCLC

The era of one-size-fits-all medicine will eventually be history; after all it is no news that drugs and treatments do not work the same for everyone. For patients with nonsmall cell lung cancer, a lung cancer that kills approximately 1 million people annually, the treatment currently available is basically the same for all patients, despite the fact that some patients may respond to treatment while others may not.

2 Jun 2010

Ablexis to advance transgenic mouse platform for antibody discovery with $12M Series A financing

Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.

2 Jun 2010

Alexion Pharmaceuticals plans to launch Soliris in Japan for patients with PNH

Alexion Pharmaceuticals, Inc. and Alexion Pharma International Sàrl today announced that the launch of Soliris (eculizumab) as a treatment for patients with PNH in Japan will begin in the third quarter of 2010, approximately three months earlier than previously expected.

2 Jun 2010

LAB Research's Canadian laboratory receives OECD-GLP compliance status

LAB Research Inc., a Canadian-based global non-clinical contract research organization, today announced that its Canadian laboratory has received a Good Laboratory Practices recognition from the Standards Council of Canada.

2 Jun 2010

Excess levels of a protein associated with TNF may produce cognitive decline: Studies

Two new studies suggest that excess levels of a protein associated with inflammation, TNF, may produce cognitive decline. TNF regulates both inflammation and brain function. TNF is elevated in the blood in many autoimmune diseases, and in the fluid surrounding the brain in Alzheimer's disease.

2 Jun 2010

Roche, ATCC partner to research real-time endogenous GPCR function with xCELLigence System

G-coupled protein receptors (GPCRs), also known as 7-transmembrane proteins, constitute the single largest class of therapeutic targets for clinical and investigational drugs. There are ~800 predicted members of this class in the human genome, involved in diverse signaling pathways in a wide array of cells and tissue types. Modulation of GPCR function has proven to have therapeutic benefit in a wide variety of diseases in immunology, neurology, cardiology, and oncology.

2 Jun 2010

Heart attack patients treated beyond maximum recommended time have increased mortality: Study

An examination of the treatment received by patients with myocardial infarction (heart attack) at 80 hospitals in Quebec indicates that those who received either primary percutaneous coronary intervention (PPCI; such as angioplasty) or fibrinolysis (administration of medication to dissolve blood clots) beyond the times recommended in international guidelines had a significantly increased risk of death within 30 days, along with an increased risk of the combined outcome of death or readmission for heart attack or heart failure at one year, according to a study in the June 2 issue of JAMA.

2 Jun 2010

GMC to participate in ProTECT III study of progesterone for emergency treatment of TBI

Geisinger Medical Center will participate in ProTECT III, a groundbreaking National Institute of Health -sponsored research study for the emergency treatment of traumatic brain injuries using the hormone progesterone.

2 Jun 2010

Functional muscle transfer surgery allows people with foot drop to walk without braces

A new surgery that involves an expendable, functioning muscle from the top of the leg and a nerve below the knee can give people with foot drop a new bounce in their step.

2 Jun 2010

UCI study provides blueprint for enhanced treatment of inflammatory diseases

By discovering how adult neural stem cells navigate to injury sites in the central nervous system, UC Irvine researchers have helped solve a puzzle in the creation of stem cell-based treatments: How do these cells know where to go? Tom Lane and Kevin Carbajal of the Sue and Bill Gross Stem Cell Research Center found the answer with the body's immune system.

2 Jun 2010

LEO Pharma to find alternative solution to withdraw pharmaceutical products from Greek market

LEO Pharma is in dialogue with the Greek authorities to find an alternative solution to withdrawing the company's pharmaceutical products from the Greek market.

2 Jun 2010

NHO introduces first healthcare assistance program for Americans, employers, groups and associations

National Health Options announces the first healthcare assistance program of its kind designed to offer an affordable, accessible, and comprehensive solution for Americans, employers, groups and associations -- including an estimated 47 million people who are underinsured or unemployed. NHO provides access to high quality healthcare products and services that can improve individual health and welfare.

2 Jun 2010

Synthetic peptide repairs, regenerates stroke-injured brain tissue

A synthetic version of a naturally occurring peptide promoted the creation of new blood vessels and repaired damaged nerve cells in lab animals, according to researchers at Henry Ford Hospital in Detroit.

2 Jun 2010

Aegis Health Group offers ten best practices to foster hospital-employer partnerships

In its latest thought paper, "Hospital-Employer Partnerships: Best Practices for Growing Market Share," Aegis Health Group offers ten best practices from hospitals across the country that have fostered mutually beneficial relationships with the employers in their area. Hospital-employer partnerships are proven to be one of the best approaches to efficiently increase market share and enhance revenue to hospitals according to Aegis, the nation's leading strategic revenue growth company for hospitals.

2 Jun 2010

CDRD, Vancouver Prostate Centre announce preferred collaboration agreement

The Centre for Drug Research and Development (CDRD) and the Vancouver Prostate Centre (VPC) today announced that they have signed a preferred collaboration agreement as the two organizations jointly strive to accelerate the discovery, development and commercialization of anti-cancer therapeutics.

2 Jun 2010

Shionogi Pharma presents study results of PSD502 for treatment of primary PE at AUA 2010

Shionogi Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd., today presented data summarizing the results of two pivotal studies of the investigational new drug PSD502, a topical metered dose spray being developed for the treatment of primary premature ejaculation. These data were presented at the 2010 American Urological Association Annual Meeting in San Francisco.

2 Jun 2010

Cook Medical's Resonance Metallic Ureteral Stent demonstrates long-term success in 29-month clinical study

A 29-month clinical study demonstrated the long-term success of Cook Medical's Resonance® Metallic Ureteral Stent in providing drainage for patients with both benign and malignant upper urinary tract obstructions, according to results presented today at the 2010 Annual Meeting of the American Urological Association (AUA). The findings suggest that metallic stents provide adequate drainage and can be maintained in situ for 12 months without significant encrustation.

2 Jun 2010

CookShop nutrition education program helps students make healthier food choices: Survey

Hundreds of New York City public elementary school teachers reported in a survey that their students are making healthier food choices because of CookShop, a nutrition education program of the Food Bank For New York City that is funded and supported by the USDA. This finding is significant at a time when 43 percent of the city's elementary school children are overweight or obese.

2 Jun 2010

Medical News

FC Barcelona agrees to make Herbalife its Official Nutrition Sponsor

ZymoGenetics commences Phase 2B study of PEG-Interferon lambda in hepatitis C

Predictive biomarker for patients with NSCLC

Ablexis to advance transgenic mouse platform for antibody discovery with $12M Series A financing

Alexion Pharmaceuticals plans to launch Soliris in Japan for patients with PNH

LAB Research's Canadian laboratory receives OECD-GLP compliance status

Excess levels of a protein associated with TNF may produce cognitive decline: Studies

Roche, ATCC partner to research real-time endogenous GPCR function with xCELLigence System

Heart attack patients treated beyond maximum recommended time have increased mortality: Study

GMC to participate in ProTECT III study of progesterone for emergency treatment of TBI

Functional muscle transfer surgery allows people with foot drop to walk without braces

UCI study provides blueprint for enhanced treatment of inflammatory diseases

LEO Pharma to find alternative solution to withdraw pharmaceutical products from Greek market

NHO introduces first healthcare assistance program for Americans, employers, groups and associations

Synthetic peptide repairs, regenerates stroke-injured brain tissue

Aegis Health Group offers ten best practices to foster hospital-employer partnerships

CDRD, Vancouver Prostate Centre announce preferred collaboration agreement

Shionogi Pharma presents study results of PSD502 for treatment of primary PE at AUA 2010

Cook Medical's Resonance Metallic Ureteral Stent demonstrates long-term success in 29-month clinical study

CookShop nutrition education program helps students make healthier food choices: Survey

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News